distamycins - CISMeF

Preferred Label : distamycins;

MeSH definition : Oligopeptide antibiotics from Streptomyces distallicus. Their binding to DNA inhibits synthesis of nucleic acids.;

Is substance : O;

Détails

Origin ID

D004214;

UMLS CUI

C0012750;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Stallimycin [NCIt concept]
Currated CISMeF NLP mapping
- Distamycin Antineoplastic Antibiotic [NCIt concept]
Pharmacological action(s)
- anti-bacterial agents [MeSH Descriptor]
- nucleic acid synthesis inhibitors [MeSH Descriptor]
Record concept(s)
- distamycins [MeSH concept]
Related MeSH Supplementary Concept(s)
- 2-imidazoledistamycin [MeSH Supplementary Concept]
- 3-(1-methyl-4-(1-methyl4-(1-methyl-4-(8-(2'-carboxamidoethyloxy)-7-methoxy-1,2,3,11a-tetrahydro-5H-pyrrolo(2,1-c)(1,4)benzodiazepin-5-one)pyrrole-2-carboxamido)pyrrole-2-carboxamido)pyrrole-2-carboxamido)propionamidine [MeSH Supplementary Concept]
- AR-1-144 [MeSH Supplementary Concept]
- FCE 24561 [MeSH Supplementary Concept]
- FCE 25450A [MeSH Supplementary Concept]
- FCE 26644 [MeSH Supplementary Concept]
- FCE 27164 [MeSH Supplementary Concept]
- FCE 27266 [MeSH Supplementary Concept]
- FCE 27784 [MeSH Supplementary Concept]
- M-bromoacetyldistamycin [MeSH Supplementary Concept]
- MEN 10710 [MeSH Supplementary Concept]
- MEN 10716 [MeSH Supplementary Concept]
- MGB-BP-3 [MeSH Supplementary Concept]
- MT 12 [MeSH Supplementary Concept]
- MT 17 [MeSH Supplementary Concept]
- N-(2-(diethylamino)ethyl)-1-methyl-4-(1-methyl-4-(4-formamido-1-methylimidazole-2-carboxamido)pyrrole-2-carboxamido)imidazole-2-carboxamide [MeSH Supplementary Concept]
- PNU 151807 [MeSH Supplementary Concept]
- PNU 153429 [MeSH Supplementary Concept]
- PNU 157977 [MeSH Supplementary Concept]
- chloroacetyldistamycin [MeSH Supplementary Concept]
- dien-microgonotropen-c [MeSH Supplementary Concept]
- distamin [MeSH Supplementary Concept]
- distamycin-DAPI [MeSH Supplementary Concept]
- distamycin-EDTA-iron(II) [MeSH Supplementary Concept]
- distel [MeSH Supplementary Concept]
- distel(2+) [MeSH Supplementary Concept]
- microgonotropen L2 [MeSH Supplementary Concept]
- microgonotropen pentaazapentabutylamine [MeSH Supplementary Concept]
- permethyldistamycin A [MeSH Supplementary Concept]
- stallimycin [MeSH Supplementary Concept]
- tallimustine [MeSH Supplementary Concept]
- thioformyldistamycin [MeSH Supplementary Concept]
- tren-microgonotropen-b [MeSH Supplementary Concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Antibiotic [UMLS semantic type]
UMLS correspondences (same concept)
- Distamycin Antineoplastic Antibiotic [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients